Healthcare -
Biotechnology - NASDAQ - US
$ 17.06
-3.62 %
$ 1.17 B
Market Cap
-6.16
P/E
ARVN - STOCK-BASED COMPENSATION
Stock-based Compensation ARVN - Arvinas, Inc.
88.2 M
LAST VALUE
8.08%
2 YEAR CAGR
34.45%
5 YEAR CAGR
0.00%
10 YEAR CAGR